Hypertrophy of future liver remnant in unresectable liver cancer following radioembolization with resin microspheres

V. Bishay(Icahn School of Medicine at Mount Sinai), R. Lookstein, Martin P. Edwards(Pfizer (United States)), F. Nowakowski(Icahn School of Medicine at Mount Sinai), A. Fischman(Mount Sinai Health System), Grace C. Lo(Icahn School of Medicine at Mount Sinai), Rahul Patel(Icahn School of Medicine at Mount Sinai), E. Kim(Icahn School of Medicine at Mount Sinai)
Journal of Vascular and Interventional Radiology
February 1, 2015
10.1016/j.jvir.2014.12.247
Cited by 1

Related Papers

Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
|Journal of Medicinal Chemistry|2011|924
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587
Using the Golden Triangle to optimize clearance and oral absorption
|Bioorganic & Medicinal Chemistry Letters|2009|382